FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

ValueSets, Authority Hl7

31,805 resources

Source: Text:

By Version

By Realm

 

Start Prev Rows 1000 - 1200 Next

PackageVersionIdentityName/TitleStatusFMMWGDateRealmSource(s)
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.833.jsonAmphenicolactive2024-02usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.834.jsonOxazolidinonesactive2024-02usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.835.jsonFluoroquinolonesactive2024-02usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.836.jsonSulfonamidesactive2024-02usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.837.jsonTetracyclinesactive2024-02usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.838.jsonPhosphonicsactive2024-02usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.839.jsonPleuromutilinactive2024-02usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.840.jsonStreptograminsactive2024-02usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.841.jsonLipoglycopeptidesactive2024-02usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.842.jsonNitroimidazolesactive2024-02usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.843.jsonPIM_Hyd_Bus_Mir_Traactive2024-02usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.844.jsonNitrofuransactive2024-02usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.845.jsonRifamycinsactive2024-02usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.846.jsonGlycylcyclineactive2024-02usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.847.jsonPyrimidinesactive2024-02usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.849.jsonAntibiotics oral and parenteralactive2024-02usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.850.jsonMedications_hyperkalemiaactive2024-03usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.852.jsonHyperkalemia_ICD10active2024-02usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.853.jsonHyperkalemia_SCTactive2024-02ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.854.jsonHyperkalemia Conditionsactive2024-02usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.855.jsonMedications_Chronic Hyperkalemiaactive2024-02usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.858.jsonPIM_Alpha_Blockers_2active2024-03usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.860.jsonPIM_Ambulatory_Visits_CPTsactive2024-03uscpt
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.862.jsonPIM_Ambulatory_Visits_SNOMEDactive2024-03ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.863.jsonPIM_Thyroid_Stimulating_Hormone_(TSH)active2024-03usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.864.jsonPIM_Triiodothyronine_(T3)active2024-03usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.865.jsonPIM_Thyroxine_(T4)active2024-03usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.866.jsonPIM_Magnesium_LOINCactive2024-03usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.867.jsonPIM_BMP_CMP_LOINCactive2024-03usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.868.jsonPIM_URIC_ACID_LOINCactive2024-03usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.869.jsonPIM_Migraine_Medicationsactive2025-04usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.870.jsonPIM_Triptansactive2024-03usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.871.jsonICS_SABA Relieveractive2024-06usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.873.jsonPIM_Asthma_COPD_Medsactive2025-03usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.874.jsonPIM_Lipid_Panel_CPTsactive2024-03uscpt
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.875.jsonPIM_Hepatic_Function_Panel_CPTsactive2024-03uscpt
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.876.jsonAlpha Glucosidase Allergy Intoleranceactive2025-04usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.877.jsonInflammatory bowel disease I10active2024-04usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.878.jsonInflammatory bowel disease SCTactive2024-04ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.879.jsonInflammatory bowel diseaseactive2024-04usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.880.jsonGastrointestinal obstruction SCTactive2024-04ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.881.jsonGastrointestinal obstruction I10active2024-04usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.882.jsonGastrointestinal obstructionactive2024-04usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.883.jsonDPP4i Allergy Intoleranceactive2025-04usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.884.jsonMultiple endocrine neoplasia type 2 (MEN II) SCTactive2024-04ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.885.jsonMultiple endocrine neoplasia type 2 (MEN II) I10active2024-04usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.886.jsonMultiple endocrine neoplasia type 2 (MEN II)active2024-04usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.887.jsonGastroparesis SCTactive2024-04ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.888.jsonGastroparesis I10active2024-04usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.889.jsonGastroparesisactive2024-04usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.890.jsonMeglitinide Allergy Intoleranceactive2025-04usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.891.jsonSulfonylurea Allergy Intoleranceactive2025-04usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.892.jsonPeripheral edema I10active2024-04usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.893.jsonPeripheral edema SCTactive2024-04ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.894.jsonPeripheral edemaactive2024-04usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.895.jsonTZD Allergy Intoleranceactive2025-05usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.896.jsonPIM_Beta_Blockersactive2024-11usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.897.jsonPIM_CCB_DHPsactive2024-11usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.898.jsonPIM_Loop_Diureticsactive2024-04usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.899.jsonPIM_Inhaled_Corticosteroids_(ICS)active2025-03usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.9.jsonACE inhibitorsactive2024-12usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.90.jsonASCVD I10active2023-09usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.900.jsonPIM_Leukotrienesactive2024-04usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.901.jsonOIA_Asthma_COPD_Meds_Inhalersactive2025-04usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.902.jsonOIA_Asthma_COPD_Meds_Nebulizersactive2024-04usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.903.jsonOIA_Asthma_COPD_Meds_Oralactive2024-04usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.904.jsonOIA_GLP1_Injectablesactive2024-04usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.905.jsonOIA_Insulin_Injectablesactive2024-04usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.906.jsonOIA_Oral_Hypoglycemicsactive2024-12usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.907.jsonOIA_DM1_DM2_Medsactive2024-10usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.908.jsonMedium Dose ICS Formoterolactive2024-05usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.909.jsonHigh Dose ICS Formoterolactive2024-05usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.910.jsonCKD stage5OrESRD I10active2024-05usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.911.jsonCKD stage5OrESRD SCTactive2024-05ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.912.jsonCKD stage5OrESRDactive2024-05usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.914.jsonAnxiety_I10active2024-06usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.915.jsonAnxiety_SCTactive2024-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.916.jsonAnxietyactive2024-06usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.918.jsonStress_SCTactive2024-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.919.jsonStress_I10active2024-06usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.920.jsonStressactive2024-06usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.921.jsonPBH_Anxiety_SCTactive2024-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.922.jsonPBH_Depression_SCTactive2024-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.923.jsonPBH_Stress_SCTactive2024-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.924.jsonPBH_Insomnia_SCTactive2024-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.925.jsonPIM_CMP_CPTsactive2024-06uscpt
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.926.jsonCanagliflozin medsactive2024-07usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.927.jsonEmpagliflozin medsactive2024-07usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.928.jsonDapagliflozin medsactive2024-07usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.929.jsonErtugliflozin medsactive2024-07usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.930.jsonDulaglutide medsactive2024-07usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.931.jsonLiraglutide medsactive2024-07usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.932.jsonSemaglutide SC medsactive2024-07usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.933.jsonT2DM meds benefitting ASCVDactive2024-07usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.934.jsonT2DM meds benefitting CKD stages 2, 3, and 4 with eGFR >= 20 mL/minactive2024-07usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.935.jsonT2DM meds benefitting CKD stage 5active2024-07usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.936.jsonT2DM meds benefitting HF with eGFR >= 20 mL/minactive2024-07usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.938.jsonCrohn disease SCTactive2024-10ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.939.jsonCrohn disease I10active2024-10usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.940.jsonCrohn diseaseactive2024-10usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.941.jsonCeliac disease SCTactive2024-10ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.942.jsonCeliac disease I10active2024-10usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.943.jsonCeliac diseaseactive2024-10usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.944.jsonOIA_Bisoprololactive2024-10usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.945.jsonOIA_PVD_ICD10active2024-10usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.946.jsonVibration Controlled Transient Elastography (VCTE)active2024-12uscpt
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.947.jsonOIA_Antihypertensive_Medicationsactive2024-10usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.950.jsonOIA_CAD_ICD10active2024-10usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.951.jsonOIA_DM_ICD10active2024-10usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.952.jsonOIA_Creatinine_Levels_LOINCactive2024-10usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.953.jsonOIA_DM_SNOMEDCTactive2024-10ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.954.jsonOIA_CAD_SNOMEDCTactive2024-10ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.955.jsonOIA_PVD_SNOMEDCTactive2024-10ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.956.jsonOIA_DM_ICD10_SNOMEDCTactive2024-10usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.957.jsonOIA_CAD_ICD10_SNOMEDCTactive2024-10usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.958.jsonOIA_PVD_ICD10_SNOMEDCTactive2024-10usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.959.jsonACEi for HFrEFactive2025-01usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.960.jsonARB for HFrEFactive2024-12usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.961.jsonOIA_AntiHTN_Meds_Inclusion_Listactive2024-11usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.962.jsonOIA_Thiazide_Diureticsactive2024-11usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.963.jsonOIA_RFs_ACS_ICD10active2024-12usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.964.jsonOIA_RFs_ACS_SNOMEDactive2024-12ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.965.jsonOIA_RFs_ACS__ICD10_SNOMEDactive2024-12usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.966.jsonOIA_Aortic_Calcifications_ICD10active2025-01usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.967.jsonOIA_Aortic_Calcifications_SNOMEDactive2025-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.968.jsonOIA_Aortic_Calcifications_ICD10_SNOMEDactive2025-01usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.969.jsonOIA_Microalbuminactive2025-01usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.97.jsonSulfonylurea AllergyIntolerance SCTactive2023-09ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.970.jsonOIA_LDL_Cholesterolactive2025-01usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.971.jsonPioglitazoneactive2025-01usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.972.jsonMASLD I10active2025-02usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.973.jsonMASLD SCTactive2025-02ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.975.jsonOIA_Sulfonylureasactive2025-01usrx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.978.jsonOIA_RFs_ASCVD_ICD10active2025-01usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.979.jsonOIA_RFs_ASCVD_SNOMEDactive2025-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.98.jsonBMI LOINCactive2024-03usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.980.jsonOIA_RFs_ASCVD_ICD10_SNOMEDactive2025-01usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.981.jsonOIA_TIA_ICD10active2025-01usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.982.jsonOIA_TIA_SNOMEDactive2025-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.983.jsonOIA_TIA_ICD10_SNOMEDactive2025-01usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.984.jsonOIA_Angina_ICD10active2025-01usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.985.jsonOIA_Angina_SNOMEDactive2025-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.987.jsonOIA_Angina_ICD10_SNOMEDactive2025-01usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.988.jsonOIA_Ischemic_Hemorrhagic_Stroke_ICD10active2025-01usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.989.jsonOIA_Ischemic_Hemorrhagic_Stroke_SNOMEDactive2025-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.990.jsonOIA_Ischemic_Hemorrhagic_Stroke_ICD10_SNOMEDactive2025-01usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.991.jsonOIA_Myocardial_Infarction_ICD10active2025-01usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.992.jsonOIA_Myocardial_Infarction_SNOMEDactive2025-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.993.jsonOIA_Myocardial_Infarction_ICD10_SNOMEDactive2025-01usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.995.jsonOIA_PAD_ICD10active2025-01usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.996.jsonOIA_PAD_SNOMEDactive2025-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.997.jsonOIA_PAD_ICD10_SNOMEDactive2025-01usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.998.jsonOIA_Coronary_Arterial_Revascularizationactive2025-01uscpt
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1080.5.jsonContact or Office Visitactive2022-02usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1080.6.jsonContact or Office Visitactive2025-02uscpt
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1080.7.jsonContact or Office Visitactive2022-02uscms
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1095.10.jsonNutrition Diagnosis SNOMED CTactive2025-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1095.101.jsonHospice Statusactive2024-10ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1095.14.jsonVitamin Mineral Supplement and Bioactive Substance Management SNOMED CTactive2020-08ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1095.17.jsonPediatric Enteral Formulas SNOMED CTactive2021-04ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1095.18.jsonModified Amino Acid Formulas SNOMED CTactive2024-04ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1095.19.jsonNutrition Counseling Approach and Strategies SNOMED CTactive2020-09ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1095.20.jsonEnteral Nutrition Management SNOMED CTactive2020-09ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1095.21.jsonNutrition Assessmentactive2024-01usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1095.25.jsonNutritional Status Severely Malnourishedactive2016-12usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1095.30.jsonMalnutrition Risk Screeningactive2015-11ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1095.31.jsonMalnutrition At Riskactive2015-11usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1095.32.jsonMalnutrition Risk Screeningactive2016-12usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1095.34.jsonMalnutrition Screening Finding of Not At Risk Resultactive2024-01usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1095.35.jsonMalnutrition Screening Not at Riskactive2015-11usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1095.38.jsonMalnutrition Screening Finding of At Risk Resultactive2025-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1095.39.jsonMalnutrition Risk Screeningactive2016-12usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1095.40.jsonMalnutrition Risk Screeningactive2022-02usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1095.41.jsonNutritional Status Severely Malnourishedactive2025-02usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1095.42.jsonNutrition Assessment Status Finding of Severely Malnourishedactive2024-12ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1095.43.jsonNutrition Assessment Status Finding of Severely Malnourishedactive2024-01usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1095.44.jsonNutrition Assessment Status Finding of Moderately Malnourishedactive2024-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1095.45.jsonNutritional Status Moderately Malnourishedactive2015-11usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1095.46.jsonNutritional Status Moderately Malnourishedactive2025-02usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1095.47.jsonNutrition Assessment Status Finding of Moderately Malnourishedactive2024-01usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1095.48.jsonNutrition Assessment Status Finding of Well Nourished or Not Malnourished or Mildly Malnourishedactive2024-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1095.49.jsonNutrition Focused Physical Findings Groupingactive2022-03usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1095.5.jsonAdult Enteral Formulas SNOMED CTactive2024-04ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1095.50.jsonEnteral Nutrition Composition SNOMED CTactive2024-04ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1095.51.jsonEnteral Nutrition Composition Groupingactive2022-03usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1095.52.jsonParenteral Nutrition Management SNOMED CTactive2020-09ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1095.53.jsonMalnutrition Diagnosisactive2024-12ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1095.54.jsonMalnutrition Diagnosisactive2025-02usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1095.55.jsonMalnutrition Diagnosisactive2022-03usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1095.56.jsonMalnutrition Diagnosisactive2016-09usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1095.59.jsonDiet Item Groupingactive2018-04usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1095.60.jsonEdible Substancesactive2021-04ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1095.61.jsonFeeding Device SNOMED CTactive2021-04ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1095.65.jsonNutrition Recommendation Groupingactive2025-02usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1095.7.jsonModular Nutrition Formulas SNOMED CTactive2021-04ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1095.71.jsonCoordination of Care by a Nutrition Professional SNOMED CTactive2024-04ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1095.73.jsonNutrition Anthropometric Measurement SNOMED CTactive2024-05ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1095.74.jsonNutrition Anthropometric Measure Panel LOINCactive2024-05usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1095.75.jsonNutrition Anthropometric Measurements Groupingactive2018-04usvsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1095.76.jsonManage Feeding Environmentactive2021-04ussct